Biotek-snakken — Maj 2024
-
-
Calliditas ahead of Q1: Patient enrollment is the lead indicaton at this stage
(RESEARCH UPDATE 2024-05-06)
"Our base case valuation is SEK 270 (270), a Bull Case of SEK 390 (390) and a Bear Case of SEK 70 (70)."
-
IRLAB: Offentliggjort i går: Samarbejdsaftale med McQuade Center for Strategic Research and Development, LCC (MSRD) om udvikling af IRL757 (middel mod apati ifm Parkinsons): https://irlab.se/mfn_news/irlab-enters-a-development-collaboration-for-irl757-as-a-novel-treatment-for-apathy/
-
IRLAB: Link til regnskabmeddelelse: https://view.news.eu.nasdaq.com/view?id=b382108fa4f0ea3918dfb1ad2b2086216&lang=en&src=listed
-
Bioportos omsætningsfremgang drevet af stærk vækst for NGAL-test i USA https://www.proinvestor.com/investornyt/1156584/bioportos-omsaetningsfremgang-drevet-af-staerk-vaekst-for-ngal-test-i-usa
-
XBRANE AND STADA PARTNER WITH VALORUM BIOLOGICS TO COMMERCIALIZE RANIBIZUMAB BIOSIMILAR CANDIDATE IN THE US
-
Photocure : Asieris' NDA For Cevira Accepted By NMPA For Regulatory Review In China https://www.proinvestor.com/investornyt/1158788/photocure-asieris-nda-for-cevira-accepted-by-nmpa-for-regulatory-review-in-china
-
Calliditas’ Partner Everest Medicines Starts Commercial Launch of Nefecon in China
Calliditas Therapeutics AB
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
Calliditas Therapeutics AB (www.calliditas.se)
-
“This is a fantastic result from many years of dedication and hard work by teams from both companies and I am delighted that patients in China now can benefit from Nefecon, which has been specifically designed to address the origin of IgAN,” said Renee Aguiar-Lucander, CEO.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind